MedTrace Logo

Timing of Initiation of Luteal Phase Support in Poor Responders Undergoing IVF/ICSI

NCT03938064 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 520

Last updated 2019-08-01

No results posted yet for this study

Summary

It is already known that all stimulated IVF ICSI cycles needs luteal phase support for higher pregnancy rates The current study will focus on evaluating two different starting times of luteal phase support

Conditions

Interventions

DRUG

Prontogest 400 mg vaginal pessaries

natural progesterone in the form of vaginal suppositories 400 mg

Sponsors & Collaborators

  • Ahmed Mahmoud Abdel-Rahim

    collaborator UNKNOWN

  • Ain Shams Maternity Hospital

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
42 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-06-26
Primary Completion
2021-01-01
Completion
2021-07-01

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03938064 on ClinicalTrials.gov